- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05792358
Våd cupping-terapi ved ankyloserende spondylitis
Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Quasi- Randomised Controlled Trial
This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
In addition to the medical treatment, WCT will be applied once every 28 days , 3 times (Day 0, 28, 56) to the intervention group whereas the control group will not receive any intervention. The BASFI, BASDAI, CRP, FFD, VAS and Modified Schober (MSI) tests will be applied to both groups at 0 and 3 months.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Karabük, Tyrkiet (Türkiye)
- Karabuk University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age between 18-65 years
- Confirmed diagnosis of ankylosing spondylitis (AS) according to the modified New York criteria or the ASAS classification criteria for axial spondyloarthritis
- Active disease at enrolment, confirmed by a PM&R specialist
- Written informed consent and compliance with the study protocol
Exclusion Criteria:
- Having received WCT within the previous 3 months
- Contraindications to WCT (hemoglobin <9.5 g/dL, known bleeding or coagulation disorders, anticoagulant use or antiplatelet therapy other than aspirin <100 mg, INR >1.5, etc.)
- Pregnancy or breastfeeding
- Severe uncontrolled comorbidities (e.g., advanced cardiovascular disease, uncontrolled diabetes, active malignancy, severe psychiatric illness)
- Any change in AS medication during the study period
- Failure to complete either baseline or follow-up visits
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Wet cupping arm
This arm is the interventiom group and will receive three consecutive sessions of wet cupping therapy once a month. |
wet cupping therapy will be applied to participants in this arm for three sessions once a month |
|
Ingen indgriben: Control arm
This arm is the control group and will not receive any intervention other than the routine medications |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
BASDAI
Tidsramme: At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Disease Activity Index |
At 0 and 9th weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Schober
Tidsramme: At 0 and 9th weeks
|
Change in the scores of Modified Schober Test |
At 0 and 9th weeks
|
|
BASFI
Tidsramme: At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Functional Index |
At 0 and 9th weeks
|
|
VAS
Tidsramme: At 0 and 9th weeks
|
Change in the scores of Visual Analogue Scale |
At 0 and 9th weeks
|
|
C Reactive Protein (CRP)
Tidsramme: At 0 and 9th weeks
|
Changes in the values of CRP |
At 0 and 9th weeks
|
|
fingertip-to-floor distance (FFD),
Tidsramme: 0 th and 9 th weeks
|
Changes in the values of fingertip-to-floor distance (FFD), |
0 th and 9 th weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SBU177
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .